Please login to the form below

Not currently logged in
Email:
Password:

Immutep

This page shows the latest Immutep news and features for those working in and with pharma, biotech and healthcare.

Immutep slumps on latest efti data in breast cancer

Immutep slumps on latest efti data in breast cancer

Analyst Dr Chris Redhead at Goetzpartners said the outcomes was a “substantial setback” for Immutep, but doesn’t mean that efti is dead. ... Immutep will need to keep its foot on the gas if it hopes to keep pace with some larger, deep-pocketed

Latest news

  • Immutep spikes on trial of its LAG-3 drug with Keytruda Immutep spikes on trial of its LAG-3 drug with Keytruda

    Impressive mid-stage results in NSCLC and HNSCC. Shares in Australian biotech Immutep rose quickly on data for its cancer immunotherapy drug eftilagimod alpha alongside Merck &Co’s Keytruda in solid ... Immutep also has a phase 2b trial of efti ongoing

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics